Answers are grounded in this paper and cite their sources.
Cord blood is increasingly used as an alternative to bone marrow transplantation in pediatric patients. Therefore, to study cord blood-derived hematopoiesis in vivo we are developing a xenogeneic transplantation model using immunodeficient SCID mice.
No takes yet. Share an insight, caveat, or question.
Vormoor et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: